These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6320039)

  • 1. Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex.
    Sheehan MJ; de Belleroche J
    Neuropeptides; 1983 Oct; 3(6):429-34. PubMed ID: 6320039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo.
    Magnani M; Mantovani P; Pepeu G
    Neuropharmacology; 1984 Nov; 23(11):1305-9. PubMed ID: 6098846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-GABA interactions in rodent cortex: analyses of cholecystokinin effects on K(+)- and L-glutamate-induced release of [3H]GABA from rat cortical slices and cultured mouse cortical neurones.
    Hickling YM; Cheung NS; Larm JA; Cowen MS; Shulkes A; Beart PM
    Neurochem Int; 1997 Feb; 30(2):171-9. PubMed ID: 9017664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in GABA content and turnover in discrete regions of rat brain after systemic administration of caerulein.
    Nakamura K; Matsumoto T; Hirano M; Uchimura H
    Psychopharmacology (Berl); 1990; 101(1):73-6. PubMed ID: 2343075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas.
    Pérez de la Mora M; Hernandez-Gómez AM; Méndez-Franco J; Fuxe K
    Eur J Pharmacol; 1993 Dec; 250(3):423-30. PubMed ID: 8112402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin releases [3H]GABA from the perfused subarachnoid space of the anaesthetized rat spinal cord.
    Rodriguez RE; Hill RG; Hughes J
    Neurosci Lett; 1987 Dec; 83(1-2):173-8. PubMed ID: 2450306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
    Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
    J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-lasting effects of peripheral injection of caerulein and CCK-8 on the central GABAergic system in mice.
    Nagahama H
    Peptides; 1989; 10(6):1247-51. PubMed ID: 2622803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of acid formation and stimulation of somatostatin release by cholecystokinin-related peptides in rabbit gastric glands.
    Bengtsson P; Lundqvist G; Nilsson G
    J Physiol; 1989 Dec; 419():765-74. PubMed ID: 2576071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholecystokinin peptides on digestive enzymes in killifish in vivo.
    Honkanen RE; Crim JW; Patton JS
    Comp Biochem Physiol A Comp Physiol; 1988; 89(4):655-60. PubMed ID: 2899485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
    Zetler G
    Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholecystokinin, caerulein and pentagastrin on electrical behavior of myenteric neurons.
    Nemeth PR; Zafirov DH; Wood JD
    Eur J Pharmacol; 1985 Oct; 116(3):263-9. PubMed ID: 4076339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat.
    Hajri A; Aprahamian M; Damgé C
    Digestion; 1989; 43(1-2):66-72. PubMed ID: 2806757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
    Zetler G
    Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperstimulation pancreatitis in mice induced by cholecystokinin octapeptide, caerulein, and novel analogues: effect of molecular structure on potency.
    Shorrock K; Austen BM; Hermon-Taylor J
    Pancreas; 1991 Jul; 6(4):404-6. PubMed ID: 1715084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caerulein and cholecystokinin reverse experimental hemorrhagic shock.
    Bertolini A; Guarini S; Ferrari W; Rompianesi E
    Neuropeptides; 1986 Jul; 8(1):25-31. PubMed ID: 3762876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.